MESSORI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.288
EU - Europa 15.574
AS - Asia 10.551
SA - Sud America 1.272
AF - Africa 281
OC - Oceania 201
Continente sconosciuto - Info sul continente non disponibili 13
Totale 55.180
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.042
RU - Federazione Russa 5.313
PL - Polonia 3.131
SG - Singapore 3.016
CN - Cina 2.633
HK - Hong Kong 1.576
IT - Italia 1.535
IE - Irlanda 1.265
SE - Svezia 1.241
VN - Vietnam 1.147
BR - Brasile 1.030
KR - Corea 921
DE - Germania 645
FI - Finlandia 527
UA - Ucraina 527
FR - Francia 451
GB - Regno Unito 400
IN - India 331
AU - Australia 193
NL - Olanda 193
JO - Giordania 153
CA - Canada 131
BD - Bangladesh 115
TR - Turchia 114
JP - Giappone 108
ES - Italia 95
ID - Indonesia 94
AR - Argentina 93
MX - Messico 67
IQ - Iraq 65
BE - Belgio 64
CH - Svizzera 61
ZA - Sudafrica 53
CI - Costa d'Avorio 47
NG - Nigeria 42
EC - Ecuador 36
PK - Pakistan 35
VE - Venezuela 33
EG - Egitto 32
AT - Austria 28
PH - Filippine 28
MA - Marocco 26
UZ - Uzbekistan 25
CL - Cile 22
CO - Colombia 21
IL - Israele 21
BG - Bulgaria 19
SA - Arabia Saudita 17
AZ - Azerbaigian 16
KE - Kenya 16
MY - Malesia 14
PY - Paraguay 14
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
IR - Iran 12
TN - Tunisia 11
DZ - Algeria 10
LT - Lituania 10
OM - Oman 10
SC - Seychelles 10
UY - Uruguay 9
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
PE - Perù 8
RO - Romania 8
AL - Albania 7
BJ - Benin 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
HN - Honduras 7
JM - Giamaica 7
KG - Kirghizistan 7
LB - Libano 7
XK - ???statistics.table.value.countryCode.XK??? 7
EU - Europa 6
HU - Ungheria 6
NI - Nicaragua 6
NP - Nepal 6
PT - Portogallo 6
AM - Armenia 5
BH - Bahrain 5
PA - Panama 5
SN - Senegal 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BO - Bolivia 4
CR - Costa Rica 4
DK - Danimarca 4
KH - Cambogia 4
LU - Lussemburgo 4
LV - Lettonia 4
MU - Mauritius 4
PS - Palestinian Territory 4
QA - Qatar 4
GE - Georgia 3
MD - Moldavia 3
ML - Mali 3
MN - Mongolia 3
NO - Norvegia 3
Totale 55.139
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.609
Warsaw 3.118
Ashburn 2.631
Fairfield 2.627
Singapore 2.090
Chandler 1.406
Hong Kong 1.274
Dublin 1.264
Woodbridge 1.249
Seattle 1.086
Cambridge 989
Houston 974
Seoul 886
Wilmington 862
Jacksonville 790
San Jose 708
Ann Arbor 568
Beijing 567
Hefei 527
Florence 403
Buffalo 360
Princeton 350
Ho Chi Minh City 326
Lauterbourg 318
Lawrence 309
The Dalles 308
Los Angeles 303
Altamura 284
Hanoi 266
Boston 260
New York 255
Moscow 212
Council Bluffs 204
Mumbai 194
Dallas 188
Boardman 186
Helsinki 182
Melbourne 168
Munich 154
San Diego 145
Shanghai 144
Medford 135
Kent 126
Amsterdam 103
Tokyo 93
Turku 93
Clifton 91
São Paulo 84
Orem 68
Jakarta 67
Norwalk 67
Brussels 62
Izmir 62
London 60
Chicago 59
Falls Church 55
Da Nang 54
Redondo Beach 54
Haiphong 52
Paris 49
Abidjan 47
Frankfurt am Main 47
Milan 45
Bern 44
Groningen 44
Toronto 44
West Jordan 42
Abuja 41
Barcelona 40
Dong Ket 40
Rome 38
Hillsboro 36
Phoenix 35
Rio de Janeiro 35
Tianjin 35
Andover 32
Bremen 32
Brooklyn 32
Guangzhou 32
Yubileyny 31
Belo Horizonte 30
Hangzhou 30
Baghdad 29
Montreal 29
Denver 27
Atlanta 26
Bologna 26
Stockholm 26
Verona 26
Johannesburg 25
Manchester 25
Chennai 24
Pisa 23
Tashkent 23
Vienna 23
Mexico City 22
Poplar 22
Auburn Hills 21
Biên Hòa 21
Porto Alegre 21
Totale 37.449
Salva come PNG Salva come JPEG
Nome #
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 656
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 403
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 377
MECHANISMS OF CYTOTOXICITY OF SELECTED ORGANOGOLD(III) COMPOUNDS 377
Proteomic Analysis of Ovarian Cancer Cell Responses to Cytotoxic Gold Compounds 351
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. 345
Solution Chemistry and Cytotoxic Properties of Novel Organogold(III) Compounds 342
Bioconjugations of proteins with 19F and nitroxide tags for in vitro and in cell characterization 336
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 336
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 330
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 326
Systems Biology of the Proteomic Analysis of Cytotoxic Gold Compounds in A2780 Ovarian Cancer Cell Line: A Network Analysis 315
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 309
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 309
New Insights into the Molecular Mechanisms of Selected Anticancer Metal Compounds through Bioinformatic Analysis of Proteomic Data 304
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes 304
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 304
Proteomic and metallomic strategies for understanding the mode of action of anticancer metallodrugs. 293
Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiae arise from inhibition of mitochondrial respiration 275
Gold(III) Compounds as a New Family of Antitumor Compounds 269
Design, synthesis and characterisation of new chimeric ruthenium(ii)-gold(i) complexes as improved cytotoxic agents 261
Mass Spectrometry and Metallomics: binding site location in the Cyt c-CDDP model system 259
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 257
Molecular Recognition of Metal Complexes by DNA: A Comparative Study of the Interactions of the Parent Complexes [PtCl(TERPY)]Cl and [AuCl(TERPY)]Cl (2) with Double Stranded DNA 254
Mass spectrometry and metallomics: stability and binding site location in the Cyt c-CDDP model system 254
Exploring the interactions of a “rule-breaker” iodo-platinum(II) complex with cytochrome c by mass spectrometry 254
Exploring metal complexes-protein/peptide interactions by high resolution mass spectrometry 252
Exploring the interactions between phosphane-based platinum(II) dichlorides and cytochrome c by electrospray ionization high resolution mass spectrometry 251
Bottom-up mass spectrometry proteomics strategies for the identification of metallodrug binding sites on proteins: the search for a general protocol to assess adduct stability 250
Unravelling the Chemical Nature of Copper Cuprizone 249
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 245
Bottom-up mass spectrometry proteomics strategies for the identification of metallodrug binding sites on proteins: the search for a general protocol to assess adduct stability 244
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 242
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 237
New gold carbene complexes as candidate anticancer agents 233
A 1H NMR study of cobalt(II) arsanilazocarboxypeptidase A 229
Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound. 226
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 225
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 224
Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD Investigation 221
(S)-(+)-2-[2-(Biphenyl-2-yl)-1-methylethyl]-4,5-dihydro-1H-imidazolium hydrogen oxalate 219
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 218
Trace Copper(II) or Zinc(II) Ions Drastically Modify the Aggregation Behavior of Amyloid-beta(1-42): An AFM Study 217
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 217
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 213
Chimica generale e inorganica 212
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation. 211
Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm) 209
A 2-Dimensional Nmr-Study Of Co(Ii)(7) Rabbit Liver Metallothionein 208
The NAMI A-human ferritin system: A biophysical characterization 207
Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. 203
[Au(9-methylcaffein-8-ylidene)2]+/DNA Tel23 System: Solution, Computational, and Biological Studies 203
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 202
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes 199
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 199
Crystallographic evidence for decomposition of dimethylformamide in the presence of ruthenium(III) chloride 198
Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS 192
The Many Lives of Auranofin: How an Old Anti-Rheumatic Agent May Become a Promising Antimicrobial Drug 191
Diruthenium Diacetate-Catalyzed Aerobic Oxidation of Hydroxylamines and Improved Chemoselectivity by Immobilization to Lysozyme 191
Antiangiogenic Properties Of Selected Ruthenium(III) Complexes That Are Nitric Oxide Scavengers 189
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu). 189
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 189
Structural Investigation of Cisplatin-Protein Interactions: Selective Platination of His 19 in Cuprozinc Superoxide Dismutase 188
Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study. 188
Metal-Based Compounds as Prospective Antileishmanial Agents: Inhibition of Trypanothione Reductase by Selected Gold Complexes 188
Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies 187
Hypericins and Thioredoxin Reductase: Biochemical and Docking Studies disclose the Molecular Basis for Effective Inhibition by Naphthodianthrones 187
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells 187
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 187
Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments 185
Decomposition of ascorbic acid in the presence of cadmium ions leads to formation of a polymeric cadmium oxalate species with peculiar structural features. 184
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 183
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme 183
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 183
Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its Zinc(II) and Copper(II) complexes 182
Au2phen and Auoxo6, Two Dinuclear Oxo-Bridged Gold({III}) Compounds, Induce Apoptotic Signaling in Human Ovarian A2780 Cancer Cells 182
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. 180
A multi-technique approach to predicting the molecular structure of cuprizone in the gas phase and in the crystalline state 180
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 179
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 177
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 176
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 176
A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteins 176
Bioconjugation of the gold drug auranofin to human ferritin yields a potent cytotoxin 175
H-1-Nmr Studies On Partially And Fully Reduced 2(4fe-4s) Ferredoxin From Clostridium-Pasteurianum 175
Cisplatin encapsulation within a ferritin nanocage: A high-resolution crystallographic study 175
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 174
The mode of action of anticancer gold-based drugs: a structural perspective 174
Large Protein Assemblies for High-Relaxivity Contrast Agents: The Case of Gadolinium-Labeled Asparaginase 173
The copper(II) coordination abilities of three novel cyclic tetrapeptides with -His-Xaa-His- motif 173
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins 173
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 173
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 172
Design and Solid Phase Synthesis of New DOTA Conjugated (+)-Biotin Dimers Planned to Develop Molecular Weight-Tuned Avidin Oligomers 172
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 172
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity 171
Exploiting soft and hard x-ray absorption spectroscopy to characterize metallodrug/protein interactions: the binding of [trans-rucl4(im)(dimethylsulfoxide)][imH] (im = imidazole) to bovine serum albumin 170
cis-Pt I2(NH3)2: a reappraisal 170
Modeling of copper(II) sites in proteins based on histidyl and glycyl residues 170
A theoretical analysis of the H Nuclear Magnetic Relaxation Dispersion profiles of diferric transferrin 170
Totale 22.974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021488 0 0 0 0 0 0 0 0 0 0 199 289
2021/20222.260 78 166 141 91 131 122 74 158 149 118 417 615
2022/20235.745 596 986 288 480 457 1.046 737 304 548 50 157 96
2023/20242.168 91 209 365 107 123 320 101 440 41 102 186 83
2024/202514.889 539 1.551 926 2.146 4.443 2.325 250 643 647 315 512 592
2025/202615.021 1.738 2.333 1.380 1.173 1.786 648 1.998 877 1.202 958 928 0
Totale 55.577